Santen Pharmaceutical Co Ltd SNPHF
Trading Information
- Previous Close Price
- $12.50
- Day Range
- $13.05–13.06
- 52-Week Range
- $8.88–13.06
- Bid/Ask
- $9.80 / $11.40
- Shares Outstanding
- 321.28M
- Market Cap
- $4.20B
- Volume/Avg
- 5,010 / 4,986
Key Statistics
- Price/Earnings (Normalized)
- 17.28
- Price/Sales
- 2.21
- Dividend Yield (Trailing)
- 1.83%
- Dividend Yield (Forward)
- 2.04%
- Dividend Payment Schedule
- Jun, Nov
- Total Yield
- 8.02%
Company Profile
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,968
- Website
- https://www.santen.com
Valuation
|
Metric
|
SNPHF
|
|---|---|
Price/Earnings (Normalized) | 17.28 |
Price/Book Value | 2.26 |
Price/Sales | 2.21 |
Price/Cash Flow | 11.00 |
Price/Earnings
SNPHF
Financial Strength
|
Metric
|
SNPHF
|
|---|---|
Quick Ratio | 1.77 |
Current Ratio | 2.60 |
Interest Coverage | 23.97 |
Quick Ratio
SNPHF
Profitability
|
Metric
|
SNPHF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SNPHF
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| LOCK|&@<xfmv | LOCK|?< | $1T | |||
| Johnson & Johnson
JNJ
| LOCK|%GYZ&W | LOCK|@D | $614B | |||
| AbbVie Inc
ABBV
| LOCK|!dcn^#D | LOCK|@lX | $471B | |||
| Merck & Co Inc
MRK
| LOCK|%fDWT&? | LOCK|M@ | $350B | |||
| Roche Holding AG ADR
RHHBY
| LOCK|DX@y&!SH | LOCK|m@r | $336B | |||
| Novartis AG ADR
NVS
| LOCK|>&HbBxFK | LOCK|bn$ | $268B | |||
| AstraZeneca PLC
AZN
| LOCK|^%C>#g$K | LOCK|w<Y | $245B | |||
| Amgen Inc
AMGN
| LOCK|VTf$Bc< | LOCK|^SV | $218B | |||
| Gilead Sciences Inc
GILD
| LOCK|^VZDhRC | LOCK|w<F | $179B | |||
| Novo Nordisk AS ADR
NVO
| LOCK|WYw&KW | LOCK|@^% | $163B |
United States